Package 59651-493-47

{"route": ["ORAL"], "spl_id": "9520c707-eb6f-4343-9e28-9820a0d22ddd", "openfda": {"nui": ["N0000020060", "N0000180187", "N0000180188", "N0000175468", "N0000175459"], "upc": ["0359651493472"], "unii": ["X4HES1O11F"], "rxcui": ["307730"], "spl_set_id": ["37761c4f-4378-472e-a41b-6a1d40575cb7"], "pharm_class_epc": ["Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]"], "pharm_class_moa": ["DNA Polymerase Inhibitors [MoA]"], "manufacturer_name": ["Aurobindo Pharma Limited"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "473 mL in 1 BOTTLE (59651-493-47)", "package_ndc": "59651-493-47", "marketing_start_date": "20220331"}], "brand_name": "ACYCLOVIR", "product_id": "59651-493_9520c707-eb6f-4343-9e28-9820a0d22ddd", "dosage_form": "SUSPENSION", "pharm_class": ["DNA Polymerase Inhibitors [MoA]", "Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Nucleoside Analog [EXT]"], "product_ndc": "59651-493", "generic_name": "ACYCLOVIR", "labeler_name": "Aurobindo Pharma Limited", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "ACYCLOVIR", "active_ingredients": [{"name": "ACYCLOVIR", "strength": "200 mg/5mL"}], "application_number": "ANDA216331", "marketing_category": "ANDA", "marketing_start_date": "20220331", "listing_expiration_date": "20261231"}